Michael MacManus

F-18-Fluorothymidine PET for Functional Response Assessment Following Radiation Therapy for Extramedullary Hematopoiesis

Belinda A Campbell, Jason Callahan, Merrole Cole-Sinclair, Michael MacManus, Michael S Hofman

Journal article  |  2021  |  CLINICAL NUCLEAR MEDICINE

ABSTRACT: As a marker of cellular proliferation, 18F-fluorothymidine (FLT) PET can detect the distribution of proliferating hemato..

Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II) The Trans Tasman Radiation Oncology Group 13.01 Phase 2 Randomized Clinical Trial

Shankar Siva, Mathias Bressel, Tao Mai, Hien Le, Shalini Vinod, Harini de Silva, Sean Macdonald, Marketa Skala, Nicholas Hardcastle, Angela Rezo, David Pryor, Suki Gill, Braden Higgs, Kassandra Wagenfuehr, Rebecca Montgomery, Raef Awad, Brent Chesson, Thomas Eade, Wenchang Wong, Giuseppe Sasso, et al.

Journal article  |  2021  |  JAMA ONCOLOGY

Importance: Evidence is lacking from randomized clinical trials to guide the optimal approach for stereotactic ablative body radio..

Nodal metabolic tumour volume on baseline F-18-FDG PET/CT and overall survival in stage II and III NSCLC patients undergoing curative-intent chemoradiotherapy/radiotherapy

Ramin Alipour, Nick Bucknell, Mathias Bressel, Sarah Everitt, Michael MacManus, Shankar Siva, Michael S Hofman, Tim Akhurst, Rodney J Hicks, Amir Iravani

Journal article  |  2021  |  JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY

INTRODUCTION: This study aims to investigate whether nodal metabolic tumour volume (nMTV) and nodal total lesion glycolysis (nTLG)..

Modern Radiation Therapy for Extranodal Nasal-Type NK/T-cell Lymphoma: Risk-Adapted Therapy, Target Volume, and Dose Guidelines from the International Lymphoma Radiation Oncology Group

Shu-Nan Qi, Ye-Xiong Li, Lena Specht, Masahiko Oguchi, Richard Tsang, Andrea Ng, Chang-Ok Suh, Umberto Ricardi, Michael Mac Manus, Bouthaina Dabaja, Joachim Yahalom

Journal article  |  2021  |  INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

In the multidisciplinary management of early-stage extranodal natural killer/T-cell lymphoma, nasal type (ENKTCL), with curative i..

Abstract CT208: Phase I Dose Escalation Study of Radiotherapy and Durvalumab (MEDI4736) in Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL): The RaDD Study

Kate Manos, Richard Khor, Geoffrey Chong, Jodie Palmer, Michael MacManus, Colm Keane, Andrew M Scott, Jake Shortt, David Ritchie, Leonid Churilov, Laura Johnston, Tom Witkowski, Allison Barraclough, Sze Ting Lee, Wendi Lin, Rachel Koldej, Eliza Hawkes

Conference Proceedings  |  2021  |  Clinical Trials

Prospective Phase II trial of radiation therapy in localised non-gastric marginal zone lymphoma with prospective evaluation of autoimmunity and Helicobacter pylori status: TROG 05.02/ALLG NHL15

Michael P MacManus, Daniel Roos, Peter O'Brien, Anne Capp, Andrew Wirth, Richard Tsang, Mathias Bressel, Stephen Lade, John F Seymour

Journal article  |  2021  |  EUROPEAN JOURNAL OF CANCER

BACKGROUND: This Phase 2 multicentre trial in localised non-gastric marginal zone lymphoma (MZL) evaluated the effectiveness and s..

Phase I Dose Escalation Study of Radiotherapy and Durvalumab (MEDI4736) in Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL): The RaDD Study.

Kate Manos, Richard Khor, Geoffrey Chong, Jodie Palmer, Michael MacManus, Colm Keane, Andrew M Scott, Jake Shortt, David Ritchie, Leonid Churilov, Laura Johnston, Tom Witkowski, Allison Barraclough, Sze Ting Lee, Wendi Lin, Rachel Koldej, Eliza Hawkes

Conference Proceedings  |  2021  |  CANCER RESEARCH

SALVAGE RADIOTHERAPY ASSOCIATES WITH DURABLE RESPONSE FOR A SUBSET OF PATIENTS WITH LIMITED STAGE REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

JH Miller, M Gilbertson, MP MacManus, A Wirth, SS Opat, GP Gregory

Conference Proceedings  |  2021  |  Hematological Oncology

A Deep Learning Model to Automate Skeletal Muscle Area Measurement on Computed Tomography Images

Kaushalya C Amarasinghe, Jamie Lopes, Julian Beraldo, Nicole Kiss, Nicholas Bucknell, Sarah Everitt, Price Jackson, Cassandra Litchfield, Linda Denehy, Benjamin J Blyth, Shankar Siva, Michael MacManus, David Ball, Jason Li, Nicholas Hardcastle

Journal article  |  2021  |  FRONTIERS IN ONCOLOGY

Background: Muscle wasting (Sarcopenia) is associated with poor outcomes in cancer patients. Early identification of sarcopenia ca..

Non-small cell lung cancer stage migration as a function of wait times from diagnostic imaging: A pooled analysis from five international centres

Jean-Pierre Bissonnette, Alexander Sun, Inga S Grills, Muayad F Almahariq, Geoffrey Geiger, Wouter Vogel, Jan-Jakob Sonke, Sarah Everitt, Michael Mac Manus

Journal article  |  2021  |  LUNG CANCER

INTRODUCTION: Patients with non-small cell lung cancer (NSCLC) can experience rapid disease progression between initial staging FD..